Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches. (2018)
Attributed to:
Manchester Academic Health Science Centre Technology Hub: Clinical Proteomics Centre for Stratified Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/leu.2017.333
PubMed Identifier: 29257138
Publication URI: http://europepmc.org/abstract/MED/29257138
Type: Journal Article/Review
Volume: 32
Parent Publication: Leukemia
Issue: 2
ISSN: 0887-6924